National Guideline Clearinghouse | Prevention and treatment of rash in patients treated with EGFR inhibitor therapies.
CancerControl Alberta
Guideline Title
Prevention and treatment of rash in patients treated with EGFR inhibitor therapies.
Bibliographic Source(s)
Alberta Provincial Thoracic Malignancies Team, Alberta Provincial Gastrointestinal Tumour Team, Alberta Provincial Head and Neck Tumour Team. Prevention and treatment of rash in patients treated with EGFR inhibitor therapies. Edmonton (Alberta): CancerControl Alberta; 2012 May. 15 p. (Clinical practice guideline; no. SUPP-003). [73 references] |
No hay comentarios:
Publicar un comentario